Literature DB >> 25981760

Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects.

Hyo Young Lee1, Hyun-Yeol Nam, Seong Kyu Shin.   

Abstract

PURPOSE: To evaluate whether an overnight or non-overnight fast for suppressing physiological FDG uptake by the myocardium is better in non-diabetic healthy subjects before F-18 FDG PET/CT studies.
MATERIALS AND METHODS: One hundred two subjects who underwent whole-body F-18 FDG PET/CT for routine health checkups were retrospectively reviewed. For quantitative assessment, a region of interest was drawn around the entire left ventricle visible in the axial view containing the highest visual uptake in order to measure the maximum standardized uptake value (SUV max). FDG uptake in the myocardium was visually graded as follows: grade 0 = minimal, 1 = mostly minimal or mild, 2 = mostly intense or moderate, and 3 = homogeneously intense. Adequate suppression of myocardial uptake was quantitatively defined as a SUV max ≤ 5.0 and grade 0 by visual assessment.
RESULTS: With regard to the SUV max, myocardial uptake was not different between the overnight and the non-overnight fasting subjects (P = 0.753). In subjects who had adequate suppression of myocardial uptake, no significant difference was observed between the overnight and non-overnight fasting subjects either in terms of visual or quantitative assessment (P = 0.539 and P = 0.678, respectively).
CONCLUSION: Both overnight and non-overnight fasts are not adequate for suppressing the physiological uptake of FDG by the myocardium.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25981760     DOI: 10.1007/s11604-015-0428-z

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  15 in total

1.  The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose.

Authors:  H J Ding; Y C Shiau; J J Wang; S T Ho; A Kao
Journal:  Nucl Med Commun       Date:  2002-10       Impact factor: 1.690

2.  Re-evaluation of myocardial FDG uptake in hyperglycemia.

Authors:  K Kubota; R Kubota; S Yamada; M Tada; T Takahashi; R Iwata
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

3.  PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake.

Authors:  Ora Israel; Michal Weiler-Sagie; Shmuel Rispler; Rachel Bar-Shalom; Alex Frenkel; Zohar Keidar; Avi Bar-Shalev; H William Strauss
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

4.  The effect of insulin and FFA on myocardial glucose uptake.

Authors:  M J Knuuti; M Mäki; H Yki-Järvinen; L M Voipio-Pulkki; R Härkönen; M Haaparanta; P Nuutila
Journal:  J Mol Cell Cardiol       Date:  1995-07       Impact factor: 5.000

5.  Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.

Authors:  Joanna Wykrzykowska; Sanaz Lehman; Gethin Williams; J Anthony Parker; Matthew R Palmer; Santosh Varkey; Gerald Kolodny; Roger Laham
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

6.  Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males.

Authors:  M Yamanouchi; K Yoshida; H Niwayama; K Nakagawa; S Aioi; N Shikama; T Himi; K Imazeki; Y Itoh; Y Masuda
Journal:  Jpn Circ J       Date:  1996-06

7.  Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle.

Authors:  A Bonen; L A Megeney; S C McCarthy; J C McDermott; M H Tan
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

8.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

Authors:  Gethin Williams; Gerald M Kolodny
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

9.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

10.  Effect of ascorbate and dehydroascorbate on tissue uptake of glucose.

Authors:  A D Mooradian
Journal:  Diabetes       Date:  1987-09       Impact factor: 9.461

View more
  4 in total

1.  Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.

Authors:  Michael T Osborne; Edward A Hulten; Venkatesh L Murthy; Hicham Skali; Viviany R Taqueti; Sharmila Dorbala; Marcelo F DiCarli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2016-06-08       Impact factor: 5.952

2.  Optimizing myocardial metabolism for fluorine-18 fluorodeoxyglucose positron emission tomography imaging of cardiac inflammation.

Authors:  Efstathia Andrikopoulou; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

3.  18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Authors:  Renata Christian Martins Felix; Clécio Maria Gouvea; Christiane Cigagna Wiefels Reis; Jacqueline Sampaio Dos Santos Miranda; Ligia Beatriz Chaves Espinoso Schtruk; Alexandre Siciliano Colafranceschi; Cláudio Tinoco Mesquita
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

4.  The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study.

Authors:  Lijun Hu; Chun Qiu; Xiaosong Wang; Mei Xu; Xiaoliang Shao; Yuetao Wang
Journal:  BMC Cardiovasc Disord       Date:  2018-10-29       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.